Skip to main content

AZN · Astrazeneca PLC · Analyst Estimates

Track AZN — free
$178.76 -3.51 (-1.93%) At close · Nov 18 Q1 2026 earnings call transcript
Market Cap
$277.24B
Shares
1.55B
Volume · Nov 18 2.54M Avg daily vol (3M) 3M

Analyst Estimates

Compare analyst forecasts for Astrazeneca PLC across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Pull consensus estimates through the analyst estimates API or MCP →

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-11-16 11:06 UTC · Publication dates shown per estimate · 7 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
10.08
10.12
10.16
2
10.05
10.07
10.05
10.09
0
0
0
1
Revenue
USD
Publication date not stated
61.91B
63.38B
64.21B
25
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
10.83
11.32
11.84
3
11.34
11.57
11.36
11.58
1
1
0
1
Revenue
USD
Publication date not stated
65.24B
67.39B
68.92B
25
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
1.74
1.74
1.74
1
1.61
0.00
0.00
0.00
0
0
— —
Revenue
USD
Publication date not stated
16.14B
16.60B
17.20B
13
— — — — — — — —

Q ending 2027-03-31

Analyst estimates for Q ending 2027-03-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
Revenue
USD
Publication date not stated
15.88B
15.98B
16.08B
2
— — — — — — — —
Key facts CIK 901832 CUSIP G0593M107 13F (30d) 1224 filings 1202 filers Visit website Investor relations